Australian regulator has a much lower threshold: Due to the risk of peripheral neuropathy, products that contain more than 50 mg are required to have the fol

Australian regulator has a much lower threshold: Due to the risk of peripheral neuropathy, products that contain more than 50 mg are required to have the following warning displayed on the product label: 'WARNING - Stop taking this medication if you experience tingling, burning or numbness and see your healthcare practitioner as soon as possible. (Contains vitamin B6)' The TGA is aware of recent reports, both in Australia and overseas, which indicate that peripheral neuropathy may occur: - at a daily dose of less than 50 mg a day of vitamin B6 - in consumers taking more than one product containing vitamin B6